BioProject
LC-MS/MS를 이용한 인체 혈장 내 세라마이드 대사물에 대한 한국 홍삼의 효과
-
AccessionKAP240413
-
Submission date2023-03-28
|
Technique type
|
Mass spectrometry (MS) |
|---|---|
|
Assay Type
|
Chromatography (MS-based) |
|
Species
|
Homo sapiens |
|
샘플 유형
|
Human |
|
추출 프로토콜
|
Plasma lipids were extracted using the Matyash method, with slight modifications. In brief, human plasma (10 µL) was aliquoted into microcentrifuge tubes containing iceꠓcold 75% methanol (400 µL) with 0.1% butylated hydroxytoluene. MTBE (1 mL) was then added, and the mixture was shaken for 1 h at room temperature. For phase separation, 250 µL water was added, and tubes were centrifuged. Aliquots of the upper phase (110 µL) and lower phase (55 µL) were transferred to new tubes, dried under a nitrogen stream, and reconstituted in 100 µL chloroform/methanol (1:9, v/v), containing the internal lipid standard (IS) mixture (40–400 ng/mL).
|
|
크로마토그래피 프로토콜
|
all lipids and the IS were separated on a Kinetex C18 column and analyzed using an LC-MS/MS system (LCMS 8060; Shimadzu, Kyoto, Japan). The mobile phase A consisted of a water/methanol mixture (1:9, v/v), with 10 mM ammonium acetate, and the mobile phase B consisted of an isopropanol/methanol mixture (5:5, v/v), with 10 mM ammonium acetate. The gradient elution was as follows: 0 min (30% B), 0–15 min (95% B), 15–20 min (95% B), and 20–25 min (30% B). The flow rate was 0.2 mL/min. Quantitation was performed in the selected reaction monitoring (SRM) of the [M + H]+ (or [M + NH4 + ]) ion and the related product ion for each lipid and IS.
|
|
질량분석 프로토콜
|
An electrospray ionization interface was used as the ionization source in the positive mode. The optimum operating conditions were as follows: capillary temperature, 350 ◦C; vaporizer temperature, 300 ◦C; collision gas (argon) pressure, 1.5 mTorr.
|
|
프로젝트의 영문 제목
|
Effect of Korean Red Ginseng on ceramide levels in human plasma using LC-MS/MS | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
프로젝트의 국문 제목
|
LC-MS/MS를 이용한 인체 혈장 내 세라마이드 대사물에 대한 한국 홍삼의 효과 | ||||||||||||
|
프로젝트의 영문 설명
|
Cardiovascular disease (CVD) is a crucial cause of death in postmenopausal women. Plasma ceramide concentrations are correlated with the development of atherosclerosis and are significant predictors of CVD. Here, we conducted a 4-week, double-blinded, placebo-controlled clinical pilot study to investigate the effect of Korean red ginseng (KRG) on serum ceramide concentrations in 68 postmenopausal women with hypercholesterolemia. | ||||||||||||
|
프로젝트의 국문 설명
|
심혈관 질환(CVD)은 폐경 후 여성의 중요한 사망 원인입니다. 혈장 세라마이드 농도는 아테롬성 동맥 경화증의 발달과 관련이 있으며 CVD의 중요한 예측 변수입니다. 여기서, 우리는 고콜레스테롤혈증을 가진 폐경기 여성 68명의 혈청 세라마이드 농도에 대한 한국 홍삼의 영향을 조사하기 위해 4주 동안 이중맹검, 위약 대조 임상 시험 연구를 수행했습니다. | ||||||||||||
|
Date and Organization
|
|
||||||||||||
|
Grant
|
|
||||||||||||
|
Publication and Patent
|
|
||||||||||||
| File Name | Size | Type | Published | Download | |
|---|---|---|---|---|---|
| Ginsenoside_[A]_1.lcd | 2,965,504 2,965,504 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_10.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_11.lcd | 3,031,040 3,031,040 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_12.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_13.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_14.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_15.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_16.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_17.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_18.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_19.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_2.lcd | 3,293,184 3,293,184 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_20.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_21.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_22.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_23.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_24.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_25.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_26.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_27.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_28.lcd | 2,965,504 2,965,504 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_29.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_3.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_30.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_31.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_32.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_33.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_34.lcd | 2,965,504 2,965,504 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_35.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_36.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_37.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_38.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_39.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_4.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_5.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_6.lcd | 3,063,808 3,063,808 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_7.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_8.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[A]_9.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_1.lcd | 3,227,648 3,227,648 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_10.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_11.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_12.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_13.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_14.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_15.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_16.lcd | 3,031,040 3,031,040 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_17.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_18.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_19.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_2.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_20.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_21.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_22.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_23.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_24.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_25.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_26.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_27.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_28.lcd | 2,965,504 2,965,504 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_29.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_3.lcd | 3,031,040 3,031,040 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_30.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_31.lcd | 3,227,648 3,227,648 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_32.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_33.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_34.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_35.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_36.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_37.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_38.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_39.lcd | 2,981,888 2,981,888 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_4.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_5.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_6.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_7.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_8.lcd | 2,998,272 2,998,272 | lcd | 2023-03-29 | ||
| Ginsenoside_[B]_9.lcd | 3,014,656 3,014,656 | lcd | 2023-03-29 | ||
| Placebo_[A]_1.lcd | 2,678,784 2,678,784 | lcd | 2023-03-29 | ||
| Placebo_[A]_10.lcd | 2,711,552 2,711,552 | lcd | 2023-03-29 | ||
| Placebo_[A]_11.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[A]_12.lcd | 2,678,784 2,678,784 | lcd | 2023-03-29 | ||
| Placebo_[A]_13.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[A]_14.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_15.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[A]_16.lcd | 2,678,784 2,678,784 | lcd | 2023-03-29 | ||
| Placebo_[A]_17.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_18.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_19.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_2.lcd | 2,707,456 2,707,456 | lcd | 2023-03-29 | ||
| Placebo_[A]_20.lcd | 2,654,208 2,654,208 | lcd | 2023-03-29 | ||
| Placebo_[A]_21.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[A]_22.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[A]_23.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[A]_24.lcd | 2,654,208 2,654,208 | lcd | 2023-03-29 | ||
| Placebo_[A]_25.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[A]_26.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[A]_27.lcd | 2,666,496 2,666,496 | lcd | 2023-03-29 | ||
| Placebo_[A]_28.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[A]_29.lcd | 2,654,208 2,654,208 | lcd | 2023-03-29 | ||
| Placebo_[A]_3.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[A]_30.lcd | 2,654,208 2,654,208 | lcd | 2023-03-29 | ||
| Placebo_[A]_31.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_32.lcd | 2,678,784 2,678,784 | lcd | 2023-03-29 | ||
| Placebo_[A]_4.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[A]_5.lcd | 2,666,496 2,666,496 | lcd | 2023-03-29 | ||
| Placebo_[A]_6.lcd | 2,695,168 2,695,168 | lcd | 2023-03-29 | ||
| Placebo_[A]_7.lcd | 2,736,128 2,736,128 | lcd | 2023-03-29 | ||
| Placebo_[A]_8.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[A]_9.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[B]_1.lcd | 2,695,168 2,695,168 | lcd | 2023-03-29 | ||
| Placebo_[B]_10.lcd | 2,703,360 2,703,360 | lcd | 2023-03-29 | ||
| Placebo_[B]_11.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[B]_12.lcd | 2,715,648 2,715,648 | lcd | 2023-03-29 | ||
| Placebo_[B]_13.lcd | 2,699,264 2,699,264 | lcd | 2023-03-29 | ||
| Placebo_[B]_14.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[B]_15.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[B]_16.lcd | 2,678,784 2,678,784 | lcd | 2023-03-29 | ||
| Placebo_[B]_17.lcd | 2,695,168 2,695,168 | lcd | 2023-03-29 | ||
| Placebo_[B]_18.lcd | 2,662,400 2,662,400 | lcd | 2023-03-29 | ||
| Placebo_[B]_19.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[B]_2.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[B]_20.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[B]_21.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[B]_22.lcd | 2,662,400 2,662,400 | lcd | 2023-03-29 | ||
| Placebo_[B]_23.lcd | 2,641,920 2,641,920 | lcd | 2023-03-29 | ||
| Placebo_[B]_24.lcd | 2,662,400 2,662,400 | lcd | 2023-03-29 | ||
| Placebo_[B]_25.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[B]_26.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[B]_27.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[B]_28.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[B]_29.lcd | 2,670,592 2,670,592 | lcd | 2023-03-29 | ||
| Placebo_[B]_3.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[B]_30.lcd | 2,682,880 2,682,880 | lcd | 2023-03-29 | ||
| Placebo_[B]_31.lcd | 2,674,688 2,674,688 | lcd | 2023-03-29 | ||
| Placebo_[B]_32.lcd | 2,686,976 2,686,976 | lcd | 2023-03-29 | ||
| Placebo_[B]_4.lcd | 2,715,648 2,715,648 | lcd | 2023-03-29 | ||
| Placebo_[B]_5.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 | ||
| Placebo_[B]_6.lcd | 2,695,168 2,695,168 | lcd | 2023-03-29 | ||
| Placebo_[B]_7.lcd | 2,723,840 2,723,840 | lcd | 2023-03-29 | ||
| Placebo_[B]_8.lcd | 2,711,552 2,711,552 | lcd | 2023-03-29 | ||
| Placebo_[B]_9.lcd | 2,691,072 2,691,072 | lcd | 2023-03-29 |
KMAP
-
대사체 데이터